How many times have you heard that term used? It happens frequently when a company announces results that are better than analysts had expected because some investors begin to believe things can only get worse. But such thinking might lead to selling too early and missing out on lucrative gains down the road.
Below is a screen of stocks that have at least doubled during the pandemic and are expected to increase sales quickly through 2024. Digging further, Mizuho Americas analyst Siti Panigrahi wrote in a note to clients that “churn rising earlier-than-expected” among small businesses with fewer than 10 employees led to the lower-than-expected guidance. Panigrahi maintained a “buy” rating on Zoom but cut his price target for the shares to $350 from $400. Even the lower price target would represent 20% upside within a year from the stock’s closing price of $292.08 on Aug. 30.
Here are the 30 companies whose stocks have at least doubled since the end of 2019 that are expected to achieve the highest compound annual growth rates for sales, through 2024. Revenue numbers are in millions:
A dark horse in the race would be the automation in medical equipment. The pandemic has vastly improved the outlook on capital expenditure for less invasive procedures. $ISRG $EDAP can see increased adoption, I have my money in $EDAP in hopes of this
Love the way drops you in the middle of reading 1 of your limited articles. Then when you have to relaunch that same article they tell you you've reached your limit so you can't finish what you started🤬🤬🤬
thanks
thanks
IpekOzkardeskay Of interest?